Methods for creating both male and female sterile plants and restoration of fertility

US2019112618A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019112618-A1
Application numberUS-201615748939-A
CountryUS
Kind codeA1
Filing dateJul 29, 2016
Priority dateJul 30, 2015
Publication dateApr 18, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are compositions and methods for creating sterile plants by genetically ablating microspore and megaspore mother cells. Also disclosed herein are methods of restoring fertility of sterile male and female plants.

First claim

Opening claim text (preview).

1 - 41 . (canceled) 42 . An isolated polynucleotide construct comprising a first polynucleotide and a second polynucleotide, the first polynucleotide comprising a SOLO-DANCERS (SDS) gene or fragment thereof, the second polynucleotide comprising a Barnase gene or fragment thereof, wherein the SDS gene comprises the SDS promoter. 43 . The isolated polynucleotide construct of claim 42 , wherein the isolated polynucleotide construct is operably linked to the SDS promoter. 44 . The isolated polynucleotide construct of claim 42 , wherein the SDS gene comprises at least one regulatory intron. 45 . The isolated polynucleotide construct of claim 44 , wherein the at least one regulatory intron comprises a sequence of any one of SEQ ID NO: 22-26 or 47-51. 46 . The isolated polynucleotide construct of claim 42 , wherein the SDS gene comprises a polynucleotide sequence of any one of SEQ ID NO: 1-21 or 29-46. 47 . The isolated polynucleotide construct of claim 42 , wherein the Barnase gene comprises a polynucleotide sequence of any one of SEQ ID NO:27. 48 . A vector comprising the isolated polynucleotide construct of claim 42 . 49 . A plant cell comprising the vector of claim 48 . 50 . A plant comprising the plant cell of claim 49 . 51 . A composition for generating a complete male sterile and female sterile transgenic plant, the composition comprising the isolated polynucleotide construct of claim 42 . 52 . The composition of claim 51 , further comprising a second isolated polynucleotide construct, wherein the second isolated polynucleotide construct comprises an inducible promoter operably linked to an artificial microRNA (amiRNA) targeted to the Barnase gene or fragment thereof, wherein the fertility of the plant is restored by inducing the expression of the amiRNA. 53 . The composition of claim 52 , wherein the amiRNA comprises a polynucleotide sequence of SEQ ID NO: 28. 54 . The composition of claim 52 , wherein the inducible promoter is an estradiol inducible promoter, an ethanol inducible promoter, a dexamethasone inducible promoter, a methoxyfenozide inducible promoter, or a temperature inducible promoter. 55 . A vector comprising the composition of claim 51 . 56 . A plant cell comprising the vector of claim 55 . 57 . A plant comprising the plant cell of claim 56 . 58 . A method for generating a complete male sterile and female sterile plant, the method comprising introducing into a target plant an isolated polynucleotide construct of claim 42 to generate a transgenic plant. 59 . A method for restoring fertility in a male sterile and female sterile transgenic plant, the method comprising: introducing into a target plant a second isolated polynucleotide construct, wherein the second isolated polynucleotide construct comprises an inducible promoter operably linked to an artificial microRNA (amiRNA) targeted to the Barnase gene or fragment thereof to generate a transgenic plant; introducing into the transgenic plant generated in (a) the isolated polynucleotide construct of claim 42 to generate a double transgenic plant; and inducing the expression of the amiRNA, thereby restoring fertility in a complete male sterile and female sterile transgenic sterile plant. 60 . The method of claim 59 , wherein the isolated polynucleotide construct and the second polynucleotide construct are encoded on the same vector or on different vectors. 61 . The method of claim 59 , wherein inducing the expression of the amiRNA comprises contacting the transgenic plant with estradiol, ethanol, dexamethasone, methoxyfenozide, or temperature.

Assignees

Inventors

Classifications

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • for fertility modification, e.g. apomixis · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Methods for controlling, regulating or enhancing expression of transgenes in plant cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019112618A1 cover?
Disclosed herein are compositions and methods for creating sterile plants by genetically ablating microspore and megaspore mother cells. Also disclosed herein are methods of restoring fertility of sterile male and female plants.
Who is the assignee on this patent?
Uwm Res Foundation Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/8287. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).